Growth Metrics

Outlook Therapeutics (OTLK) Cash from Investing Activities (2016 - 2019)

Outlook Therapeutics (OTLK) has disclosed Cash from Investing Activities for 5 consecutive years, with -$1.0 as the latest value for Q3 2019.

  • Quarterly Cash from Investing Activities rose 100.0% to -$1.0 in Q3 2019 from the year-ago period, while the trailing twelve-month figure was -$437307.0 through Sep 2019, up 84.28% year-over-year, with the annual reading at -$900000.0 for FY2020, 105.81% down from the prior year.
  • Cash from Investing Activities for Q3 2019 was -$1.0 at Outlook Therapeutics, up from -$150737.0 in the prior quarter.
  • The five-year high for Cash from Investing Activities was $46949.0 in Q1 2016, with the low at -$3.5 million in Q2 2015.
  • Average Cash from Investing Activities over 5 years is -$632910.3, with a median of -$202226.5 recorded in 2018.
  • The sharpest move saw Cash from Investing Activities crashed 5165.95% in 2018, then surged 100.0% in 2019.
  • Over 5 years, Cash from Investing Activities stood at -$364242.0 in 2015, then skyrocketed by 59.27% to -$148362.0 in 2016, then plummeted by 624.68% to -$1.1 million in 2017, then surged by 78.01% to -$236433.0 in 2018, then surged by 100.0% to -$1.0 in 2019.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$1.0, -$150737.0, and -$50136.0 for Q3 2019, Q2 2019, and Q1 2019 respectively.